Amicus Therapeutics Stock Market Value
| FOLD Stock | USD 10.33 0.22 2.09% |
| Symbol | Amicus |
Amicus Therapeutics Price To Book Ratio
Is Amicus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amicus Therapeutics. If investors know Amicus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amicus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.50) | Revenue Per Share 1.353 | Quarterly Revenue Growth 0.306 | Return On Assets (0.06) | Return On Equity (1.07) |
The market value of Amicus Therapeutics is measured differently than its book value, which is the value of Amicus that is recorded on the company's balance sheet. Investors also form their own opinion of Amicus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Amicus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amicus Therapeutics' market value can be influenced by many factors that don't directly affect Amicus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amicus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amicus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amicus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Amicus Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amicus Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amicus Therapeutics.
| 03/19/2024 |
| 04/18/2024 |
If you would invest 0.00 in Amicus Therapeutics on March 19, 2024 and sell it all today you would earn a total of 0.00 from holding Amicus Therapeutics or generate 0.0% return on investment in Amicus Therapeutics over 30 days. Amicus Therapeutics is related to or competes with Home Federal, Betterware, Provident Bancorp, Heartland Financial, Nordea Bank, Conflux Network, and Citigroup Capital. Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rar... More
Amicus Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amicus Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amicus Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 12.72 | |||
| Value At Risk | (4.81) | |||
| Potential Upside | 3.67 |
Amicus Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amicus Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amicus Therapeutics' standard deviation. In reality, there are many statistical measures that can use Amicus Therapeutics historical prices to predict the future Amicus Therapeutics' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.17) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Amicus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Amicus Therapeutics Backtested Returns
Amicus Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0834, which signifies that the company had a -0.0834% return per unit of risk over the last 3 months. Amicus Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amicus Therapeutics' Risk Adjusted Performance of (0.07), mean deviation of 1.93, and Standard Deviation of 2.54 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.87, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Amicus Therapeutics will likely underperform. Amicus Therapeutics has an expected return of -0.21%. Please make sure to confirm Amicus Therapeutics total risk alpha, kurtosis, price action indicator, as well as the relationship between the value at risk and rate of daily change , to decide if Amicus Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.26 |
Poor predictability
Amicus Therapeutics has poor predictability. Overlapping area represents the amount of predictability between Amicus Therapeutics time series from 19th of March 2024 to 3rd of April 2024 and 3rd of April 2024 to 18th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amicus Therapeutics price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current Amicus Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 0.2 |
Amicus Therapeutics lagged returns against current returns
Autocorrelation, which is Amicus Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Amicus Therapeutics' stock expected returns. We can calculate the autocorrelation of Amicus Therapeutics returns to help us make a trade decision. For example, suppose you find that Amicus Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Amicus Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Amicus Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Amicus Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Amicus Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Amicus Therapeutics Lagged Returns
When evaluating Amicus Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Amicus Therapeutics stock have on its future price. Amicus Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Amicus Therapeutics autocorrelation shows the relationship between Amicus Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Amicus Therapeutics.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Amicus Therapeutics Correlation, Amicus Therapeutics Volatility and Amicus Therapeutics Alpha and Beta module to complement your research on Amicus Therapeutics. For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Amicus Stock analysis
When running Amicus Therapeutics' price analysis, check to measure Amicus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicus Therapeutics is operating at the current time. Most of Amicus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Amicus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicus Therapeutics' price. Additionally, you may evaluate how the addition of Amicus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Amicus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.